Is KRAS up or down today?
KRAS is down 0.37% today, last at 152.79. This stock moved -0.37% versus the prior close.
KRAS · KRAS
KRAS (KRAS) is trading at 152.79, down 0.37% on the session. KRAS sits at the 50% mark of its 52-week range.
Leading the coverage: “Verastem: A Rare-Disease Launch Is Financing A KRAS G12D Platform (NASDAQ:VSTM) - Seeking Alpha” (Google News Company, 5d ago). KRAS is +13.57% since story.
KRAS trades on a trailing P/E of 13.5.
Analyst firms are mostly reiterating — no strong directional shift lately.
KRAS is down 0.37% today, last at 152.79. This stock moved -0.37% versus the prior close.
Leading the coverage: “Verastem: A Rare-Disease Launch Is Financing A KRAS G12D Platform (NASDAQ:VSTM) - Seeking Alpha” (Google News Company, 5d ago). KRAS is +13.57% since story. Dominant story: Verastem: A Rare-Disease Launch Is Financing A KRAS G12D Platform (NASDAQ:VSTM) - Seeking Alpha (1 source, neutral) RSI unavailable Price sits at 50% of its 52-week range Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Historical price chart unavailable
Live quote in the header is real, but OHLC history could not be loaded from Yahoo Finance or fallback providers. Charts use Yahoo when configured correctly — check server logs for provider errors.
Verastem: A Rare-Disease Launch Is Financing A KRAS G12D Platform (NASDAQ:VSTM) - Seeking Alpha
Incyte (INCY) Stock Could Be 31% Stretched Following KRAS Data Buzz - simplywall.st
Incyte (INCY) Nears New ESMO Data For KRAS G12D Candidate 734 - Yahoo Finance
Incyte Corporation (INCY) vs. Revolution Medicines (RVMD): Which Biotech Stock Offers the Better KRAS Opportunity? - Yahoo Finance
Croatia's Kras to withdraw 94,069 own shares - SeeNews